Overview

Gender

male

Investor Type

Investment Partner

William Newman is managing director at Northwest Technology Ventures, a $14 million Oregon seed fund focusing on technology-based startups and spinouts from the research sector in both life sciences and technology.

In addition to Adapx, representative investments include Ambric, developing a novel semiconductor architecture; Receptor Biologix, developing receptor antagonists for cancer; and Artielle Immunotherapeutics, with an immunomodulatory platform based on recombinant receptor ligands.

Bill earned a Ph.D. in mechanical engineering and applied mathematics at Ecole Polytechnique in France prior to joining the research faculty at MIT, where he also earned an MBA from MIT’s Sloan School of Management.

While at MIT he directed a joint program at MIT and the Harvard Medical School to develop cancer treatment modalities. Discoveries from that research resulted in patented inventions that formed the basis for two spinouts.

He serves on numerous corporate boards, and on various academic and civic boards including chair of the Oregon Bioscience Association and Oregon’s Innovation Council.